BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 16680151)

  • 1. Identification of a tumour suppressor network opposing nuclear Akt function.
    Trotman LC; Alimonti A; Scaglioni PP; Koutcher JA; Cordon-Cardo C; Pandolfi PP
    Nature; 2006 May; 441(7092):523-7. PubMed ID: 16680151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of protein kinase CK2 attenuates FOXO3a functioning in a PML-dependent manner: implications in human prostate cancer.
    Chatterjee A; Chatterjee U; Ghosh MK
    Cell Death Dis; 2013 Mar; 4(3):e543. PubMed ID: 23492774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network.
    Song MS; Salmena L; Carracedo A; Egia A; Lo-Coco F; Teruya-Feldstein J; Pandolfi PP
    Nature; 2008 Oct; 455(7214):813-7. PubMed ID: 18716620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.
    Bernardi R; Guernah I; Jin D; Grisendi S; Alimonti A; Teruya-Feldstein J; Cordon-Cardo C; Simon MC; Rafii S; Pandolfi PP
    Nature; 2006 Aug; 442(7104):779-85. PubMed ID: 16915281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
    Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
    Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release.
    Giorgi C; Ito K; Lin HK; Santangelo C; Wieckowski MR; Lebiedzinska M; Bononi A; Bonora M; Duszynski J; Bernardi R; Rizzuto R; Tacchetti C; Pinton P; Pandolfi PP
    Science; 2010 Nov; 330(6008):1247-51. PubMed ID: 21030605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic PML function in TGF-beta signalling.
    Lin HK; Bergmann S; Pandolfi PP
    Nature; 2004 Sep; 431(7005):205-11. PubMed ID: 15356634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purinergic receptor-mediated rapid depletion of nuclear phosphorylated Akt depends on pleckstrin homology domain leucine-rich repeat phosphatase, calcineurin, protein phosphatase 2A, and PTEN phosphatases.
    Mistafa O; Ghalali A; Kadekar S; Högberg J; Stenius U
    J Biol Chem; 2010 Sep; 285(36):27900-10. PubMed ID: 20605778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.
    Imoto N; Hayakawa F; Kurahashi S; Morishita T; Kojima Y; Yasuda T; Sugimoto K; Tsuzuki S; Naoe T; Kiyoi H
    J Biol Chem; 2016 Feb; 291(9):4723-31. PubMed ID: 26703467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
    Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
    Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor alpha transcriptionally activates casein kinase 2 alpha: A pivotal regulator of promyelocytic leukaemia protein (PML) and AKT in oncogenesis.
    Das N; Datta N; Chatterjee U; Ghosh MK
    Cell Signal; 2016 Jun; 28(6):675-87. PubMed ID: 27012497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E6AP promotes the degradation of the PML tumor suppressor.
    Louria-Hayon I; Alsheich-Bartok O; Levav-Cohen Y; Silberman I; Berger M; Grossman T; Matentzoglu K; Jiang YH; Muller S; Scheffner M; Haupt S; Haupt Y
    Cell Death Differ; 2009 Aug; 16(8):1156-66. PubMed ID: 19325566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.
    Saitoh N; Uchimura Y; Tachibana T; Sugahara S; Saitoh H; Nakao M
    Exp Cell Res; 2006 May; 312(8):1418-30. PubMed ID: 16688858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of promyelocytic leukemia protein in human gastric cancers.
    Lee HE; Jee CD; Kim MA; Lee HS; Lee YM; Lee BL; Kim WH
    Cancer Lett; 2007 Mar; 247(1):103-9. PubMed ID: 16713073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts.
    Cairo S; De Falco F; Pizzo M; Salomoni P; Pandolfi PP; Meroni G
    Oncogene; 2005 Mar; 24(13):2195-203. PubMed ID: 15735755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient mutations alter ATRX targeting to PML nuclear bodies.
    Bérubé NG; Healy J; Medina CF; Wu S; Hodgson T; Jagla M; Picketts DJ
    Eur J Hum Genet; 2008 Feb; 16(2):192-201. PubMed ID: 17957225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PML-associated repressor of transcription (PAROT), a novel KRAB-zinc finger repressor, is regulated through association with PML nuclear bodies.
    Fleischer S; Wiemann S; Will H; Hofmann TG
    Exp Cell Res; 2006 Apr; 312(6):901-12. PubMed ID: 16412420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
    Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
    Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer.
    Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A
    J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PML positively regulates interferon gamma signaling.
    El Bougrini J; Dianoux L; Chelbi-Alix MK
    Biochimie; 2011 Mar; 93(3):389-98. PubMed ID: 21115099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.